{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:08:25Z","timestamp":1776985705894,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009123","name":"Norges Teknisk-Naturvitenskapelige Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019902","name":"Fakultet for medisin og helsevitenskap, Norges Teknisk-Naturvitenskapelige Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004590","name":"Helse Midt-Norge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013263","name":"Nasjonalforeningen for Folkehelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007849","name":"Respiratory Health Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.atherosclerosis.2019.07.024","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T01:55:34Z","timestamp":1564106134000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3045-5407","authenticated-orcid":false,"given":"Torbj\u00f8rn","family":"Velle-Forbord","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Eidlaug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Debik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Caroline","family":"S\u00e6ther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turid","family":"Follestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javaid","family":"Nauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4508-7990","authenticated-orcid":false,"given":"Bruna","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helge","family":"R\u00f8sj\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torbj\u00f8rn","family":"Omland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Langaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1259-5542","authenticated-orcid":false,"given":"Anja","family":"Bye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cob.12009","article-title":"Trends in overweight and obesity over 22 years in a large adult population: the HUNT Study, Norway","volume":"3","author":"Midthjell","year":"2013","journal-title":"Clinical obesity"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib2","first-page":"1511","article-title":"Prevalence of diabetes mellitus in Norway,","volume":"124","author":"Stene","year":"2004","journal-title":"Tidsskr Nor L\u00e6geforen"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European society of cardiology: cardiovascular disease statistics 2017","volume":"39","author":"Atlas Writing","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2261-13-123","article-title":"Evaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithms","volume":"13","author":"Kariuki","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib5","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00259-012-2254-1","article-title":"Prediction models for risk classification in cardiovascular disease","volume":"39","author":"Petretta","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39261.471806.55","article-title":"Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study","volume":"335","author":"Hippisley-Cox","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib9","first-page":"286","article-title":"Model for estimation of cardiovascular risk in Norway","volume":"128","author":"Selmer","year":"2008","journal-title":"Tidsskr Nor L\u00e6geforen"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","volume":"28","author":"Graham","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/HJR.0b013e3283213140","article-title":"How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators","volume":"16","author":"Cooney","year":"2009","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","article-title":"The effect of including C-reactive protein in cardiovascular risk prediction models for women","volume":"145","author":"Cook","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib14","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-156-6-201203200-00006","article-title":"Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study","volume":"156","author":"Kavousi","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCGENETICS.112.964148","article-title":"Clinical utility of genetic variants for cardiovascular risk prediction: a futile exercise or insufficient data?","volume":"5","author":"Di Angelantonio","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/aje\/kwm060","article-title":"Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study","volume":"166","author":"Morrison","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib19","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib20","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.111.075929","article-title":"Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative","volume":"125","author":"Cook","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.109.912568","article-title":"Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction","volume":"123","author":"Wang","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib23","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.ijcard.2012.07.018","article-title":"Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score","volume":"167","author":"Lyngbaek","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib24","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/CIR.0b013e3182051bab","article-title":"ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"122","author":"Greenland","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/heartjnl-2013-305402","article-title":"MicroRNAs in cardiovascular disease: an introduction for clinicians","volume":"101","author":"Romaine","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.atherosclerosis.2015.06.037","article-title":"The role of microRNAs in coronary artery disease: from pathophysiology to diagnosis and treatment","volume":"241","author":"Economou","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14712590902932889","article-title":"MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases","volume":"9","author":"Cortez","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib28","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood- based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumour- associated microRNAs in serum of patients with diffuse large B-cell lymphoma","volume":"141","author":"Lawrie","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib31","doi-asserted-by":"crossref","first-page":"985408","DOI":"10.1155\/2014\/985408","article-title":"MicroRNAs expression profiles in cardiovascular diseases","volume":"2014","author":"Bronze-da-Rocha","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib33","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","article-title":"Prospective study on circulating MicroRNAs and risk of myocardial infarction","volume":"60","author":"Zampetaki","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yjmcc.2016.05.009","article-title":"Circulating microRNAs predict future fatal myocardial infarction in healthy individuals - the HUNT study","volume":"97","author":"Bye","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145930","article-title":"miRNA-197 and mirna-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease","volume":"10","author":"Schulte","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib36","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ije\/dys095","article-title":"Cohort profile: the HUNT study, Norway","volume":"42","author":"Krokstad","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib37","series-title":"Hard Coronary Heart Disease (10-year Risk)","author":"Framingham Heart Study","year":"2016"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ahj.2007.02.027","article-title":"Prediction of first coronary events with the Framingham score: a systematic review","volume":"153","author":"Eichler","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gheart.2013.01.001","article-title":"Cardiovascular disease risk assessment: insights from Framingham","volume":"8","author":"D'Agostino","year":"2013","journal-title":"Global heart"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib40","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057496","article-title":"Circulating microRNAs and aerobic fitness-- the HUNT-Study","volume":"8","author":"Bye","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091812","article-title":"Prognostic value of circulating microRNA-210 levels in patients with moderate to severe aortic stenosis","volume":"9","author":"R\u00f8sj\u00f8","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC bioinformatics [electronic resource]"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib44","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib45","series-title":"The Elements of Statistical Learning","author":"Hastie","year":"2009"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib47","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and obesity as determinants of cardiovascular risk: the Framingham experience","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib48","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study","volume":"366","author":"Yusuf","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.yjmcc.2010.08.007","article-title":"Synergistic effects of the GATA-4-mediated miR- 144\/451 cluster in protection against simulated ischemia\/reperfusion-induced cardiomyocyte death","volume":"49","author":"Zhang","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib50","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708046","article-title":"miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders","volume":"10","author":"Widlansky","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib51","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.113.301780","article-title":"MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP\/SMAD1 signaling","volume":"113","author":"Icli","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000369713","article-title":"A dysregulated microRNA-26a\/EphA2 axis impairs endothelial progenitor cell function via the p38 MAPK\/VEGF pathway","volume":"35","author":"Zuo","year":"2015","journal-title":"Cell. Physiol. Biochem. : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2016.09.067","article-title":"The role of miRNAs in cardiovascular disease risk factors","volume":"254","author":"Jones Buie","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib54","first-page":"66","article-title":"Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans, Clinica chimica acta","volume":"412","author":"Li","year":"2011","journal-title":"international journal of clinical chemistry"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000351767","article-title":"Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease","volume":"50","author":"Tsai","year":"2013","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib56","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1038\/srep05026","article-title":"Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases","volume":"4","author":"Jiang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fgene.2014.00099","article-title":"miR-191: an emerging player in disease biology","volume":"5","author":"Nagpal","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00281-009-0149-4","article-title":"CRP and the risk of atherosclerotic events","volume":"31","author":"Calabro","year":"2009","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/CIRCRESAHA.111.300539","article-title":"Circulating microRNAs as novel biomarkers for platelet activation","volume":"112","author":"Willeit","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib60","doi-asserted-by":"crossref","first-page":"31596","DOI":"10.1038\/srep31596","article-title":"Structural and functional characterization of endothelial microparticles released by cigarette smoke","volume":"6","author":"Serban","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib61","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yjmcc.2016.05.009","article-title":"Circulating microRNAs predict future fatal myocardial infarction in healthy individuals - the HUNT study","volume":"97","author":"Bye","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bib\/bbv056","article-title":"Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR","volume":"17","author":"Marabita","year":"2016","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib63","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1373\/clinchem.2012.199505","article-title":"Heparin selectively affects the quantification of microRNAs in human blood samples","volume":"59","author":"Boeckel","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib64","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib65","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.108.777334","article-title":"Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events","volume":"118","author":"Mora","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib66","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.108.804146","article-title":"Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction","volume":"118","author":"Langsted","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib67","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Emerging Risk Factors","year":"2009","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib68","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2014"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib69","series-title":"Bestglm: Best Subset GLM and Regression Utilities","author":"McLeod","year":"2018"},{"key":"10.1016\/j.atherosclerosis.2019.07.024_bib70","author":"Wei"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019314261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019314261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:24:20Z","timestamp":1762187060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019314261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":70,"alternative-id":["S0021915019314261"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.07.024","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}